Riggs Asset Managment Co. Inc. Gilead Sciences, Inc. Transaction History
Riggs Asset Managment Co. Inc.
- $321 Million
- Q1 2025
A detailed history of Riggs Asset Managment Co. Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 156 shares of GILD stock, worth $17,231. This represents 0.01% of its overall portfolio holdings.
Number of Shares
156
Previous 155
0.65%
Holding current value
$17,231
Previous $14,000
21.43%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
2,287Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.57 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.03 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.91 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...